Alyeska Investment Group’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $332K | Buy |
+6,795
| New | +$332K | ﹤0.01% | 527 |
|
|
2023
Q4 | – | Sell |
-360,000
| Closed | -$8.07M | – | 573 |
|
|
2023
Q3 | $8.07M | Buy |
360,000
+10,000
| +3% | +$224K | 0.05% | 303 |
|
|
2023
Q2 | $14.2M | Buy |
350,000
+200,000
| +133% | +$8.13M | 0.11% | 230 |
|
|
2023
Q1 | $7.27M | Buy |
+150,000
| New | +$7.27M | 0.06% | 272 |
|
|
2018
Q2 | – | Sell |
-30,000
| Closed | -$812K | – | 469 |
|
|
2018
Q1 | $812K | Buy |
+30,000
| New | +$812K | 0.01% | 366 |
|
|
2015
Q4 | – | Sell |
-24,158
| Closed | -$645K | – | 439 |
|
|
2015
Q3 | $645K | Buy |
+24,158
| New | +$645K | 0.01% | 404 |
|
|
2014
Q1 | – | Sell |
-119,440
| Closed | -$2.03M | – | 324 |
|
|
2013
Q4 | $2.03M | Buy |
119,440
+95,540
| +400% | +$1.62M | 0.08% | 189 |
|
|
2013
Q3 | $513K | Sell |
23,900
-111,100
| -82% | -$2.38M | 0.02% | 237 |
|
|
2013
Q2 | $2.03M | Buy |
+135,000
| New | +$2.03M | 0.1% | 165 |
|